Compare Mabion SA (272) vs. Competitors

0 Followers

Comparison Results

272

Mabion SA

€1.63

€29.46M

-2.29

-16.85%

―

Ryvu Therapeutics SA

zł27.65

zł381.48M

-5.48

-40.22%

―

Scope Fluidics SA

zł118.00

zł409.97M

-7.60

-19.02%

―

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.

zł3.72

zł215.52M

-9.94

-32.66%

―

Captor Therapeutics SA

zł42.20

zł406.62M

-8.25

67.54%

―

OncoArendi Therapeutics SA

zł5.95

zł164.66M

-10.41

-12.71%

―

xxxxxxxxxxxxx

272 vs MOC

xxxxxxxxxxxxx

Performance Comparison

DE:272

Mabion SA

1.69

-0.27

-13.97%

PL:RVU

Ryvu Therapeutics SA

16.50

-9.70

-37.02%

PL:SCP

Scope Fluidics SA

129.40

-37.60

-22.51%

PL:SVE

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.

2.84

-1.32

-31.69%

PL:CTX

Captor Therapeutics SA

64.00

25.90

67.98%

PL:MOC

OncoArendi Therapeutics SA

6.66

-0.74

-10.00%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >